MALABSORPTION FROM APPLICATION SITE

This adverse event was reported 153 times

These drugs are most commonly taken by patients reporting MALABSORPTION FROM APPLICATION SITE:

# Drug Count
0 ESTRADIOL 36
1 ESTRADIOL GEL 0.1% 11
2 ESTRADIOL TRANSDERMAL 11
3 ESTRADIOL, 11
4 BRINZOLAMIDE/BRIMONIDINE TARTRATE 8
5 TESTOSTERONE 8
6 BUPRENORPHINE 7
7 NEPAFENAC 7
8 ASPIRIN 6
9 ASPIRIN 325 MG 6
See all common drugs associated with MALABSORPTION FROM APPLICATION SITE

MALABSORPTION FROM APPLICATION SITE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CLASCOTERONE 4 0.0028
1 NEPAFENAC 7 0.0022
2 BRINZOLAMIDE/BRIMONIDINE TARTRATE 8 0.0019
3 ESTRADIOL ACETATE 1 0.0013
4 12%AZELAIC ACID 1 0.0012
5 AZELAIC ACID 1 0.0010
6 ESTRADIOL 36 0.0004
7 INSULIN ASPART INJECTION 1 0.0004
8 PRASTERONE 1 0.0004
9 ESTROGEN 1 0.0003
See all drugs enriched for association with MALABSORPTION FROM APPLICATION SITE

MALABSORPTION FROM APPLICATION SITE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Carbonic Anhydrase Inhibitor [EPC] 8 0.0004
1 Androgen [EPC] 8 0.0003
2 Estrogen [EPC] 42 0.0002
3 Allylamine Antifungal [EPC] 1 0.0001
4 Provitamin D2 Compound [EPC] 3 0.0001
5 Partial Opioid Agonist [EPC] 7 0.0001
6 Androgen Receptor Inhibitor [EPC] 4 0.0001
7 Progesterone [EPC] 1 0.0000
8 Tetracycline-class Drug [EPC] 2 0.0000
9 P2Y12 Platelet Inhibitor [EPC] 3 0.0000
See all drug classes enriched for association with MALABSORPTION FROM APPLICATION SITE